Founded at the Abramson Cancer Center at the University of Pennsylvania

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia

By John K. Lin; Benjamin J. Lerman; James I. Barnes; Brian C. Boursiquot; Yuan Jin Tan; Alex Q.L. Robinson; Kara L. Davis; Douglas K. Owens; Jeremy D. Goldhaber-Fiebert

Projects

Approaches to Foster Economic Sustainability of Precision Cancer Medicine and Cell Therapies

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia

Journal of Clinical Oncology | 2018

John K. Lin; Benjamin J. Lerman; James I. Barnes; Brian C. Boursiquot; Yuan Jin Tan; Alex Q. L. Robinson; Kara L. Davis; Douglas K. Owens; Jeremy D. Goldhaber-Fiebert